Salmeterol xinafoate with EDMF CTD / CEP applied

We are pleased to inform you that our Indian manufacturing partner Vamsi Labs Limited has submitted the European Drug Master File in CTD-format for API SALMETEROL XINAFOATE (Antiasthmatics) to EDQM in Straßbourg and applied for Certificate of Suitability.

If you need any further explanations, price indications, analytical samples etc. please let us know - we will try to help you in any case. The applicant's part of the EDMF CTD can be handed out against Secrecy Agreement.

Looking forward to hearing from you.

Your F. & A. PHARMA team

Back to News